Literature DB >> 31773296

Dose independent characterization of renal stones by means of dual energy computed tomography and machine learning: an ex-vivo study.

Nils Große Hokamp1, Simon Lennartz2,3, Johannes Salem4, Daniel Pinto Dos Santos2, Axel Heidenreich4, David Maintz2, Stefan Haneder2.   

Abstract

OBJECTIVES: To predict the main component of pure and mixed kidney stones using dual-energy computed tomography and machine learning.
METHODS: 200 kidney stones with a known composition as determined by infrared spectroscopy were examined using a non-anthropomorphic phantom on a spectral detector computed tomography scanner. Stones were of either pure (monocrystalline, n = 116) or compound (dicrystalline, n = 84) composition. Image acquisition was repeated twice using both, normal and low-dose protocols, respectively (ND/LD). Conventional images and low and high keV virtual monoenergetic images were reconstructed. Stones were semi-automatically segmented. A shallow neural network was trained using data from ND1 acquisition split into training (70%), testing (15%) and validation-datasets (15%). Performance for ND2 and both LD acquisitions was tested. Accuracy on a per-voxel and a per-stone basis was calculated.
RESULTS: Main components were: Whewellite (n = 80), weddellite (n = 21), Ca-phosphate (n = 39), cysteine (n = 20), struvite (n = 13), uric acid (n = 18) and xanthine stones (n = 9). Stone size ranged from 3 to 18 mm. Overall accuracy for predicting the main component on a per-voxel basis attained by ND testing dataset was 91.1%. On independently tested acquisitions, accuracy was 87.1-90.4%.
CONCLUSIONS: Even in compound stones, the main component can be reliably determined using dual energy CT and machine learning, irrespective of dose protocol. KEY POINTS: • Spectral Detector Dual Energy CT and Machine Learning allow for an accurate prediction of stone composition. • Ex-vivo study demonstrates the dose independent assessment of pure and compound stones. • Lowest accuracy is reported for compound stones with struvite as main component.

Entities:  

Keywords:  Artificial intelligence; Kidney calculi; Machine learning; Tomography, X-ray computed

Mesh:

Substances:

Year:  2019        PMID: 31773296     DOI: 10.1007/s00330-019-06455-7

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  6 in total

1.  [A nonlocal spectral similarity-induced material decomposition method for noise reduction of dual-energy CT images].

Authors:  L Wang; Y Wang; Z Bian; J Ma; J Huang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-05-20

Review 2.  Machine Learning for Renal Pathologies: An Updated Survey.

Authors:  Roberto Magherini; Elisa Mussi; Yary Volpe; Rocco Furferi; Francesco Buonamici; Michaela Servi
Journal:  Sensors (Basel)       Date:  2022-07-01       Impact factor: 3.847

Review 3.  Artificial Intelligence Applications in Urology: Reporting Standards to Achieve Fluency for Urologists.

Authors:  Andrew B Chen; Taseen Haque; Sidney Roberts; Sirisha Rambhatla; Giovanni Cacciamani; Prokar Dasgupta; Andrew J Hung
Journal:  Urol Clin North Am       Date:  2021-10-23       Impact factor: 2.766

4.  Machine Learning Prediction of Kidney Stone Composition Using Electronic Health Record-Derived Features.

Authors:  Abin Abraham; Nicholas L Kavoussi; Wilson Sui; Cosmin Bejan; John A Capra; Ryan Hsi
Journal:  J Endourol       Date:  2022-02       Impact factor: 2.942

5.  Value of artificial intelligence model based on unenhanced computed tomography of urinary tract for preoperative prediction of calcium oxalate monohydrate stones in vivo.

Authors:  Lei Tang; Wuchao Li; Xianchun Zeng; Rongpin Wang; Xiushu Yang; Guangheng Luo; Qijian Chen; Lihui Wang; Bin Song
Journal:  Ann Transl Med       Date:  2021-07

Review 6.  The Ascent of Artificial Intelligence in Endourology: a Systematic Review Over the Last 2 Decades.

Authors:  B M Zeeshan Hameed; Milap Shah; Nithesh Naik; Bhavan Prasad Rai; Hadis Karimi; Patrick Rice; Peter Kronenberg; Bhaskar Somani
Journal:  Curr Urol Rep       Date:  2021-10-09       Impact factor: 3.092

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.